Genetic Variant Linked to Development of Liver Cancer in HCV Carriers (2 of 2) (IMAGE)
Caption
Comparison of DEPDC5 expression level in cancerous liver tissue. Left: Results from study of liver samples from 43 hepatitis-C carriers with liver cancer showed that DEPDC5 was more highly expressed in cancerous tissue than in non-cancerous tissue. Right: Proportion of cases in which expression of DEPDC5 was at least five times greater in cancerous tissue than in non-cancerous tissue was high in groups that had the risk variant (TG+GG).
Credit
RIKEN
Usage Restrictions
None
License
Licensed content